W
Wiebke Hellenbrand
Researcher at Robert Koch Institute
Publications - 81
Citations - 2348
Wiebke Hellenbrand is an academic researcher from Robert Koch Institute. The author has contributed to research in topics: Vaccination & Tick-borne encephalitis. The author has an hindex of 25, co-authored 74 publications receiving 2078 citations. Previous affiliations of Wiebke Hellenbrand include Pasteur Institute.
Papers
More filters
Journal ArticleDOI
The seroepidemiology of herpes simplex virus type 1 and 2 in Europe
Richard Pebody,Nick Andrews,David Brown,Robin Gopal,H.E. de Melker,Guido François,Nina Gatcheva,Wiebke Hellenbrand,Sari Jokinen,I Klavs,Mira Kojouharova,T Kortbeek,B. Kriz,Katarina Prosenc,K Roubalova,P Teocharov,W. Thierfelder,M. Valle,P. Van Damme,R. Vranckx +19 more
TL;DR: There is large variation in the seroepidemiology of herpes simplex virus types 1 and 2 in the general populations of eight European countries, particularly in northern Europe, and the observation that a significant proportion of adolescents are now HSV-1 susceptible may have implications for transmission and clinical presentation.
Journal ArticleDOI
A super-spreading ewe infects hundreds with Q fever at a farmers' market in Germany
Klaudia Porten,Jürgen Rissland,Almira Tigges,Susanne Broll,Wilfried Hopp,Mechthild Lunemann,Ulrich van Treeck,Peter Kimmig,Stefan O Brockmann,Christiane Wagner-Wiening,Wiebke Hellenbrand,Udo Buchholz +11 more
TL;DR: It was recommended that pregnant sheep not be displayed in public during the 3rd trimester and to test animals in petting zoos regularly for C. burnetii as a consequence of this outbreak.
Journal ArticleDOI
Changing epidemiology of Q fever in Germany, 1947-1999.
TL;DR: The seasonality of community outbreaks has shifted from predominantly winter- spring to spring-summer, possibly because of changes in sheep husbandry, and the location of recent outbreaks suggests that urbanization of rural areas may be contributing to the increase in Q fever.
Journal ArticleDOI
Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010.
Ole Wichmann,Petra Stöcker,Gabriele Poggensee,Doris Altmann,Dietmar Walter,Wiebke Hellenbrand,Gérard Krause,Tim Eckmanns +7 more
TL;DR: During the 2009 influenza pandemic, a monovalent AS03-adjuvanted vaccine was almost exclusively used in Germany for immunisation against the 2009 pandemic influenza A(H1N1) virus.
Journal ArticleDOI
The epidemiology of pertussis in Germany: past and present
Wiebke Hellenbrand,Dietmar Beier,Evelin Jensen,Martina Littmann,Christiane Meyer,Hanna Oppermann,Carl-Heinz Wirsing von König,Sabine Reiter +7 more
TL;DR: The shift in pertussis morbidity to older age groups observed in FEG is similar to reports from other countries with longstanding vaccination programs and suggests that additional booster vaccination may be necessary beyond adolescence.